# Processa Pharmaceuticals, Inc.: Form 8-K/A, filed Oct 5, 2026

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K/A
- Filed: 2026-10-05
- Accepted by EDGAR: Oct 5, 2026, 07:21 ET
- Period: 2026-07-23
- Accession: 0001140361-26-038535
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_8ka.htm

Filed Oct 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-038535. Last ingested by Listed: Nov 5, 2026, 12:19 ET. No prices; not investment advice.